AstraZeneca赞助的临床试验
总计4307个结果
-
AstraZenecaUniversity of Oxford; University of Manchester完全的
-
First Hospital of China Medical UniversityAstraZeneca未知
-
Annick DesjardinsAstraZeneca; Novartis Pharmaceuticals完全的
-
AstraZenecaISTITUTO REGINA ELENA - CENTRO RICERCHE SPERIMENTALI终止
-
Intergroupe Francophone de Cancerologie ThoraciqueSanofi; AstraZeneca完全的
-
AstraZenecaInstitute of Cancer Research, United Kingdom完全的
-
University of North Carolina, Chapel HillAstraZeneca尚未招聘
-
ETOP IBCSG Partners FoundationAstraZeneca AG Switzerland尚未招聘
-
Mario Negri Institute for Pharmacological ResearchAstraZeneca招聘中
-
Emory UniversityNational Cancer Institute (NCI); AstraZeneca招聘中套细胞淋巴瘤 | 边缘区淋巴瘤 | 淋巴浆细胞性淋巴瘤 | 淋巴增生性疾病 | 惰性非霍奇金淋巴瘤 | 1 级滤泡性淋巴瘤 | 2 级滤泡性淋巴瘤 | 3a 级滤泡性淋巴瘤美国
-
University Hospital Southampton NHS Foundation...AstraZeneca招聘中
-
Dana-Farber Cancer InstituteAstraZeneca; Osteosarcoma Institute招聘中
-
Anwaar SaeedAstraZeneca; Exelixis主动,不招人
-
National Cancer Institute (NCI)AstraZeneca; NRG Oncology主动,不招人复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 卵巢浆液性癌 | 卵巢未分化癌 | 卵巢透明细胞腺癌 | 输卵管移行细胞癌 | 卵巢移行细胞癌 | 输卵管透明细胞腺癌 | 输卵管未分化癌 | 复发性卵巢子宫内膜样腺癌 | 卵巢子宫内膜样瘤 | 卵巢浆液性肿瘤美国, 加拿大, 大韩民国, 日本
-
Mario Negri Institute for Pharmacological ResearchAstraZeneca完全的
-
University College, LondonAstraZeneca; Cancer Research UK主动,不招人
-
University of BirminghamAstraZeneca; Cancer Trials Ireland主动,不招人
-
Sanofi Pasteur, a Sanofi CompanyAstraZeneca主动,不招人
-
Massachusetts General HospitalAstraZeneca; Astex Pharmaceuticals, Inc.主动,不招人
-
Trisha Wise-DraperAstraZeneca主动,不招人
-
Ulrich KeilholzCharite University, Berlin, Germany; AstraZeneca完全的
-
Northwestern UniversityNational Cancer Institute (NCI); AstraZeneca主动,不招人转移性前列腺癌 | IV 期前列腺癌 | 前列腺癌转移性去势抵抗 | 异常DNA修复美国
-
Austrian Breast & Colorectal Cancer Study GroupAstraZeneca完全的
-
First Affiliated Hospital of Zhejiang UniversityAstraZeneca主动,不招人
-
University of Michigan Rogel Cancer CenterAstraZeneca终止
-
Vanderbilt-Ingram Cancer CenterAstraZeneca; Syndax Pharmaceuticals终止输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 卵巢子宫内膜样腺癌 | 复发性子宫内膜癌 | 卵巢透明细胞腺癌 | 输卵管透明细胞腺癌 | 输卵管子宫内膜样腺癌 | 原发性腹膜浆液性腺癌 | 输卵管癌肉瘤 | 卵巢癌肉瘤 | 高级别卵巢浆液性腺癌 | 高级别输卵管浆液性腺癌美国
-
AstraZenecaThe Cleveland Clinic; IQVIA RDS Inc.完全的符合条件的男性或女性被认为是动脉粥样硬化性心血管疾病 (CVD) 的高风险人群美国, 比利时, 意大利, 荷兰, 丹麦, 台湾, 波兰, 俄罗斯联邦, 大韩民国, 匈牙利, 英国, 中国, 新西兰, 捷克语, 澳大利亚, 南非, 乌克兰, 日本, 加拿大, 墨西哥, 立陶宛, 爱沙尼亚
-
Spanish Breast Cancer Research GroupPfizer; AstraZeneca完全的
-
University of Texas Southwestern Medical CenterAstraZeneca终止
-
University of Texas Southwestern Medical CenterAstraZeneca完全的
-
Sheffield Teaching Hospitals NHS Foundation TrustAstraZeneca完全的
-
University of Sao Paulo General HospitalAstraZeneca未知
-
Sheffield Teaching Hospitals NHS Foundation TrustAstraZeneca完全的
-
Dartmouth-Hitchcock Medical CenterAstraZeneca; Augusta University完全的
-
Hospital Universitari Vall d'Hebron Research InstituteAstraZeneca未知
-
AstraZenecaBristol-Myers Squibb; University of Pennsylvania完全的
-
University College, LondonAstraZeneca; Cancer Research UK撤销
-
University Hospital, AkershusAstraZeneca; Haukeland University Hospital完全的
-
University College, LondonAstraZeneca; Cancer Research UK完全的
-
Weill Medical College of Cornell UniversityAstraZeneca终止